China · Series B startup

Who invested in Jike Xueyuan

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 31 Oct 2026

$22Mraised across 2 rounds since 2013, from 2 sources

Latest round
Series B, $22MSept 2014
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2014
?Venture$22MSeries B
First round
Venture
Mar 2013
Biggest round
$22M
Series B · Sept 2014
Between rounds
19 months
from the last two

The rounds

  1. Sept 2014
    Series B$22M2 new

    From a historical funding record

  2. Mar 2013
    VentureAmount undisclosed1 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2013Series B2014M12BlueRun VenturesSIG

Everyone who backed them

M12Corporate VC1round
BlueRun VenturesVC firm1round
SIGInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Jike Xueyuan

Who invested in Jike Xueyuan?

Jike Xueyuan's investors include M12, BlueRun Ventures and SIG.

How much has Jike Xueyuan raised?

Jike Xueyuan has raised $22M across 2 rounds since 2013. One round did not disclose an amount, so the total is a floor.

When did Jike Xueyuan last raise?

Jike Xueyuan's most recent round was a Series B of $22M in Sept 2014.

What was Jike Xueyuan's biggest round?

Its most recent round, $22M in Sept 2014, is also its largest on record.

Who backed Jike Xueyuan first?

Jike Xueyuan's first round on record, in Mar 2013, was backed by M12.

What stage is Jike Xueyuan at?

Jike Xueyuan's latest named round is a Series B, in Sept 2014.

Where is Jike Xueyuan based?

Jike Xueyuan is based in China.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.